Avinger, Inc. (NASDAQ: AVGR) experienced a significant surge in premarket trading today, jumping by an impressive 46% following a rather lackluster performance the previous day,
Avinger, Inc. (AVGR) gained in the pre-market after announcing its reverse stock split in a press release. AVGR values at $3.95, gaining more than 2,094.44%
On January 14, Avinger Inc. (AVGR) announced the successful closing of its $7.6 million registered direct offering. Consequently, the stock saw an upsurge in the
On February 17, American stock exchanges closed in different directions. The S&P 500 index dropped by a purely symbolic 0.03%, to 3931 points, the NASDAQ
Last week indices in the United States managed to set fresh records on the price boards. Interestingly, we saw Wall Street indices initially take a
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is a
Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.